3

FORM 3 SUBMISSION

Company: ROCKET PHARMACEUTICALS, INC.
Filed: February 17, 2015
Period of Report: February 17, 2015
Accession Number: 0001209191-15-014862

View Document ↗ View on SEC.gov ↗